Blog

  • Kolling researcher honoured with prestigious, international role

    Kolling researcher honoured with prestigious, international role

    Congratulations to the Kolling’s Acting Executive Director Professor Chris Little following his election to the Board of Directors of the Orthopaedic Research Society.

    It is regarded as the world’s leading orthopaedic research society, representing clinicians and researchers across the scientific spectrum from fundamental science to clinical research and clinical trials.

    Professor Little, the Director of the Raymond Purves Bone and Joint Research Lab, has been elected to the high-profile, international board for two years.

    “I’m deeply honoured to have been elected to the board, and excited to be part of this world-leading musculoskeletal research society,” he said.

    “I have been a member of the society for more than 20 years, and it’s been a critical part of my research over that time, providing collaborations and mentors that have shaped my career.

    “I would like to support the society so it can have the same positive impact on today’s emerging musculoskeletal researchers as it did for me.

    “Despite the scale of musculoskeletal diseases across the community, there is a clear need for additional funding and support, and fresh ideas. The sector is often the poor cousin when it comes to key announcements.

    “There’s a tremendous number of people and organisations working across the musculoskeletal field, and I’m convinced that by working together, we will be in a better position to secure additional funding and improve long-term health outcomes.

    “It really begins and ends with excellence in research, and if we provide an environment of learning, mentorship and collaboration, and enable great research across the sector, we will make tangible health gains.” 

  • Researchers offer new approach to detect frailty in older adults

    Researchers offer new approach to detect frailty in older adults

    A team of researchers led by the Kolling’s Professor Sarah Hilmer has developed a valuable resource to identify frail and vulnerable people in hospital, in an important step towards optimising their care.

    Frail older adults have a higher risk of experiencing adverse outcomes in hospital such as falls, confusion and malnutrition, and many have longer hospital stays.

    Professor Hilmer said more than 26,000 people in Northern Sydney are frail, representing a quarter of the population over 70.

    “Fortunately, frailty can be managed, and in some cases reversed if detected early and provided with the appropriate care,” she said.

    The frailty tool developed by our team uses existing data from hospital electronic medical records, and does not require clinical staff to fill-out additional forms. Steps are now being taken to automate the process within the medical records system.

    “The tool can be used to measure the prevalence of frailty amongst patients in our hospitals, and this will help ensure that models of care meet their needs.

    “The patient’s frailty could also be communicated to their general practitioner on discharge to guide their ongoing care in the community.

    “This important new resource will help with early recognition and appropriate management, leading to better health outcomes and a better quality of life when people go home.”

    Sarita Lo, the research pharmacist who helped develop the tool said it will help ensure we have adequate support to care for frail older people in hospital, whether it be geriatric medicine expertise, specialist nursing, physiotherapy, a medication review or nutrition advice.

  • New medication may offer long-acting relief for those with knee osteoarthritis

    New medication may offer long-acting relief for those with knee osteoarthritis

    A study has been launched to investigate the benefits of a new injectable medication for those with knee osteoarthritis.

    The condition can have a profound impact on a person’s life, leading to physical limitations, ongoing pain and joint instability.

    There are broader implications too which can make it difficult for those with the condition to engage in social, community and occupational activities.

    Significant resources and expertise are being directed towards the disease, and a number of clinical trials and research studies are underway to develop new interventions and tests that may alleviate the symptoms of the condition.

    One of these promising trials is being led by Professor David Hunter and his team from the Kolling Institute and Royal North Shore Hospital.

    The Excellence Study will evaluate a new injectable medication that has been formulated to provide both short-term and long-acting relief from pain, inflammation and mobility impairments.

    Many current medications for knee osteoarthritis offer only short-term relief, while this new medication may offer relief for up to six months. 

    Volunteers are being recruited for the study and further community support is needed.

    Details about the eligibility criteria can be found in the registration survey form.

    Interested volunteers can click on the link provided in the form to register their interest for the study.

    To find out more: https://redcap.sydney.edu.au/surveys/?s=4T7XWDW33T

    Contact: Tatyana Fedorova 9463 1774

  • Global focus on musculoskeletal health

    Global focus on musculoskeletal health

    Kolling researchers are part of an international team calling for musculoskeletal health to become a global priority, addressing a current lack of funding for the world’s leading cause of pain.

    The project team found the management of musculoskeletal health is under-prioritised despite its impact on the community, and devised an action plan to address this gap.

    Led by Professors Andrew Briggs and Helen Slater from Curtin University, the project involved Professor Lyn March from the Kolling Institute and Dr Carmen Huckel-Schneider and Swatee Mishrra of the University of Sydney, as well as a broader international team.

    It mapped the current landscape for musculoskeletal health, identified trends in national health policies and developed a blueprint to prioritise musculoskeletal health. This work was informed by stakeholders from more than 70 countries.

    Professor Briggs said more than 1.5 billion people live with a musculoskeletal condition, such as low back pain, fractures, arthritis and osteoporosis, but despite calls to action, health systems continued to under-prioritise these conditions.  

    “One of the limiting factors to reform is that no global-level strategic response to the burden of disability has been developed – until now. This initiative will be critical to guiding global-level work in health reform, such as that undertaken by the World Health Organization,” Professor Briggs said.

    “This blueprint will provide guidance which countries, including low and middle-income countries, can then adapt to suit local needs and priorities.”

    Professor March said the framework focuses on critical areas for reform, including community education; leadership and governance; health financing models; service delivery models that support integrated and person-centred care; equitable access to medicines and technologies; building capacity in the health workforce to deliver the right care at the right time; population health surveillance; and research and innovation.

    “The blueprint is practical and can inform what a global strategic response might look like and how countries can respond to musculoskeletal health in order to arrest the increasing global burden of disability and cost,” she said.

    The project was commissioned by the Global Alliance for Musculoskeletal Health and funded by the Bone and Joint Foundation, with additional funding provided by Curtin University.

    The international team of researchers are from Curtin University, the Kolling Institute, University of Sydney, University of Toronto, Canadian Memorial Chiropractic College, Kathmandu University and the University of Southern Denmark.

    The report ‘Towards a global strategy to improve musculoskeletal health’ can be found at the Global Alliance for Musculoskeletal Health

NSWGOV logo